5 U.S. Stocks Gaining Strong Momentum in Pre-market Trading
2026-07-15
Pre-market trading rarely stays quiet for long, and today is no exception. A handful of US stocks with strong momentum in pre-market trading are lighting up scanners well before the opening bell, and most of them share a familiar profile: small floats, thin liquidity, and a spark of news that sends volume through the roof.
Anyone tracking a pre-market gainer list this week has likely already noticed the names below, since they combine explosive percentage moves with volume that dwarfs their usual daily averages.
This piece breaks down each stock, why it moved, and what the pattern means if you trade momentum names.
Key Takeaways
Five stocks, NXTC, SHPH, UBXG, LHAI, and VMAR, are leading U.S. stocks pre-market gainer lists, with moves ranging from roughly 29% to over 300%.
The biggest driver is a reverse merger and financing deal at NextCure, while the others are largely momentum, volume, and sector rotation plays.
These are almost all low-float micro-cap or nano-cap names, which means the same volatility that creates fast gains can just as easily produce a sharp reversal after the open.
What Counts as a Pre-market Gainer? (Answer-First Definition)
A pre-market gainer is simply a stock whose price rises sharply during the pre-market session, which runs before the regular 9:30 a.m. ET open. Because volume is thin during these hours, even a moderate number of buy orders can push a stock's price far more than it would during normal trading.
That is exactly what is happening across US stocks pre-market trading right now, where a cluster of low-float names is seeing outsized percentage swings on relatively modest dollar volume.
At a Glance
In Simple Terms
Think of pre-market trading as a narrow doorway. Only a fraction of the market's usual participants are awake and active, so when a wave of buyers rushes through, the price gets pushed much harder than it would during the busy regular session.
That is why a stock like NXTC can jump over 300% before most traders have even had their coffee. It is not that the company suddenly became three times more valuable; it is that a small number of shares changing hands can swing the price wildly when liquidity is this thin.
Read Also: Why Bolivia Consider USDT for National Payment System?
The 5 Stocks Leading Pre-market Momentum
NXTC, NextCure, Inc.

NextCure surged the most on this list, up 323.85% in pre-market trading to around $9.24, on volume near 41.67 million shares. The move followed news of a major all-stock merger with Avere Therapeutics, under which Avere shareholders would end up owning roughly 98% of the combined company.
The deal also includes a $320 million financing package, including convertible notes, to fund AVR-001, a once-weekly oral IL-23 therapy aimed at psoriasis and related conditions. The transaction is expected to close in the second half of 2026.
Before this news, NXTC was a distressed, loss-making biotech with a tiny market cap, which explains why a large capital injection and a fresh pipeline asset triggered such an extreme reaction. Dilution from the financing and execution risk on the new program remain real concerns once the initial excitement fades.
SHPH, Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals climbed 51.01% pre-market to roughly $4.47 on strong volume of about 22 million shares. This is a tiny clinical-stage company, with only a couple of employees, developing treatments designed to enhance radiation and other cancer therapies.
There is no clearly identified company-specific headline behind the move; it looks more like momentum spillover from other biotech movers, including NXTC, combined with the stock's naturally low float.
Names like this tend to swing hard on any positive signal, short covering, or simple volume spikes, so the rally says more about market structure than fundamentals.
UBXG, U-BX Technology Ltd.

U-BX Technology gained 43.49% in pre-market trading, reaching about $9.04 on volume near 2.69 million shares. The company provides AI-driven services to insurance carriers and brokers in China and went public relatively recently, in 2024.
No major fresh news explains the jump, so this appears largely technical, possibly a short squeeze layered on top of broader AI and China-tech rotation. Given the stock's already high volatility and a downtrend earlier in the year, traders should treat this move cautiously.
LHAI, Linkhome Holdings Inc.
Linkhome Holdings rose 43.00% pre-market to around $1.43, with an enormous 40.55 million shares changing hands. Linkhome runs an AI-driven real estate platform covering buying, selling, brokerage, and renovation services, and it went public in 2025.
The scale of the volume relative to the company's size points to heavy retail participation, likely amplified by short covering, rather than any single confirmed catalyst. As a recent IPO with a high beta, it remains sensitive to both company-specific news and broader shifts in market sentiment.
VMAR, Vision Marine Technologies Inc.

Vision Marine Technologies gained 29.08% pre-market, trading near $1.82 on volume around 38 million shares. Unlike some of the others on this list, VMAR has an actual fundamental trigger: its Q3 2026 results showed 27% quarter-over-quarter revenue growth along with improved gross margins and positive operating cash flow.
The company designs electric outboard powertrains and boats under its E-Motion platform, and recent news about facility expansions, patents, and partnerships has kept the electric marine narrative alive.
It is still a micro-cap with a history of losses, so the risk profile stays elevated even with genuine operational progress behind the move.
Read Also: What Is Digital Ruble? Understanding Russia's New Digital Currency
Key Entities Behind the Move
Understanding who and what is driving these headlines helps put the moves in context. NextCure and Avere Therapeutics anchor the biggest story on the list through their merger and financing deal.
TradingView's pre-market screeners are the primary data source traders use to spot these movers in real time. Sector themes matter too, since biotech reverse mergers, AI adoption, and electric marine or EV technology are each contributing narrative fuel to different names on this list.
Common Mistakes Traders Make With Pre-market Gainers
Chasing the headline percentage without checking the float size is one of the most common errors, since a 300% move on a stock with only a few million shares outstanding behaves very differently from the same move on a heavily traded name.
Another mistake is ignoring dilution risk, especially in cases like NXTC, where a large financing round can quietly increase share count even as the underlying news looks bullish.
Traders also frequently place market orders in illiquid pre-market sessions, which can result in filling far above the price they intended. Finally, many assume pre-market strength will hold into the regular session, when in reality a large share of these moves fade, or reverse entirely, once broader liquidity returns at the open.
Interpretation Cheat Sheet
A pre-market move driven by a merger or financing deal, like NXTC, tends to be more durable but carries dilution risk. A move with no clear news, like SHPH or UBXG, is more likely to be pure momentum and prone to fading quickly.
A move backed by actual earnings or revenue growth, like VMAR, sits somewhere in between: it has real substance, but the stock remains small and volatile enough that gains can still evaporate fast.
Read Also: Digital Ruble to Be Launched on September 1 by the Central Bank of Russia
Trading These Themes Beyond Crypto
Momentum in individual US equities like these is exciting, but it is also high-risk by nature, and it is not the only way to gain exposure to U.S. market movements. For traders who want a more structured way to access American equities, Bitrue's TradFi trading platform offers exposure to tokenized U.S. stocks alongside crypto assets, all from a single account.
If you are new to this style of trading, this guide to trading TradFi assets on Bitrue walks through how it works, and this breakdown of tokenized U.S. stocks from Nvidia to SpaceX shows the range of names available.
Registering an account on Bitrue takes just a few minutes and opens the door to both crypto and tokenized equity markets in one place.
Expert Summary
Today's pre-market leaderboard is a textbook case of how low-float, small-cap stocks react to news, rumor, and thin liquidity. NextCure's merger and financing news is the clearest, most substantial catalyst on the list, while Shuttle Pharmaceuticals and U-BX Technology look more like momentum and squeeze plays riding sector sentiment.
Linkhome's volume spike reflects retail enthusiasm more than confirmed news, and Vision Marine stands out as the one name backed by genuine, reported financial improvement.
Across the board, the message for traders is consistent: these moves offer real opportunity, but they demand tight risk management given how quickly pre-market strength can unwind once the regular session opens.
Read Also: What is Euro Stablecoin (EURXT)?
FAQ
What does it mean when a stock has strong pre-market momentum?
It means the stock's price is rising quickly during the hours before the market officially opens, usually driven by news, low float, or heavy buying interest relative to the stock's normal volume.
Why did NXTC (NextCure) jump so much in pre-market trading?
NXTC surged after announcing a reverse merger with Avere Therapeutics alongside a $320 million financing deal to fund a new psoriasis therapy, which dramatically changed the company's outlook and attracted heavy trading volume.
Are pre-market gainers safe to trade?
No, they carry significant risk. Most pre-market gainers are low-float, small-cap stocks with thin liquidity, so prices can reverse sharply once regular trading hours begin and volume normalizes.
How can I track U.S. stocks pre-market gainer lists in real time?
Platforms like TradingView offer live pre-market screeners that rank stocks by percentage change and volume, which is where lists like this one are typically sourced from.
Is pre-market volume a reliable signal on its own?
Not entirely. High volume shows strong interest, but it does not confirm a lasting catalyst. It is best combined with checking the news, company fundamentals, and float size before drawing conclusions.
Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.
Disclaimer: The content of this article does not constitute financial or investment advice.




